FDA tells labs to remove faulty coronavirus antibody tests from stock

By LabPulse.com staff writers

June 22, 2020 -- The U.S. Food and Drug Administration (FDA) has advised labs not to use antibody tests for the novel coronavirus that have been found to have low performance and to remove them from stock.

The agency has published a list of products that have been removed from the market, either voluntarily by manufacturers or by FDA requirement, and will be continually updating it on its list of frequently asked questions web page. In a letter to lab professionals and health providers on June 19, the agency said that tests on the "removed list" should be taken out of stock and that patients tested with them previously may need to be retested as the results may have been incorrect.

Whereas at the beginning of the COVID-19 pandemic, the FDA had lax rules on market entry for tests, allowing products to be sold without review by the agency, it introduced stricter requirements for performance criteria and timing on applying for emergency use authorizations in May. The FDA also recently revoked emergency use authorization for Chembio's serology test.

Real-world data project will help FDA assess COVID-19 diagnostics
The U.S. Food and Drug Administration (FDA) plans to use real-world data to evaluate and foster development of COVID-19 molecular and antibody tests through...
FDA paves way for mass coronavirus screening of asymptomatic people
The U.S. Food and Drug Administration (FDA) has published guidance for diagnostics developers that it said will enable broad diagnostic testing of asymptomatic...
FDA finds false results with Chembio coronavirus antibody test, revokes clearance
The U.S. Food and Drug Administration (FDA) has revoked an emergency use authorization for Chembio Diagnostic Systems' antibody test for the novel coronavirus,...
FDA airs antibody test performance specs, educational video
The U.S. Food and Drug Administration (FDA) has published detailed performance specifications for four more commercial antibody tests. Separately, the...
FDA pulls plug on wayward coronavirus antibody tests
The U.S. Food and Drug Administration (FDA) has published the names of 28 coronavirus antibody tests that may no longer be marketed or distributed, as...

Copyright © 2020 LabPulse.com

Last Updated ls 6/22/2020 10:16:37 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current